R&D Data-driven disease research harnessing the genome Ben Hargreaves speaks to the UK Biobank to learn more about their work building a dataset of 500,000 individuals.
R&D This week in clinical trials: 2nd-5th January 2024 Despite the multiple challenges that faced clinical trials in 2023, according to GlobalData’s Pharmaceutical Intelligence Centre, some 22,338
Market Access Big pharma is slimming down The last few years have been marked by many big pharma companies opting to move away from diversification and towards more focused operations.
Market Access ABPI Annual Conference 2023 – patients, partnerships, and po... Attending this year’s Association of British Pharmaceutical Industry (ABPI) Conference in London on Thursday 27th April, it quickly became clear that the day would be a notable one – not ju
R&D Around the world in pharma events Stay up to date with key industry meetings and conferences in 2023 Americas FT US Pharma & Biotech Summit 16-17-May New York, US
R&D Inside the new world of healthcare data These days, real-world data collection is in vogue and not hard to come by in healthcare research.
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
